Leung, C
What may appear as tolerance is often attributable to other factors such as dietary adaptation, metabolic compensation, or progression of underlying disease rather than true receptor-level tolerance to the medication itself
Beyond improving glycemic balance, semaglutide also reduces appetite, curbs food cravings, and supports better control over eating
GLP-1 medications dont cure fatigue, but for many patients, they address enough of the underlying contributors that energy levels improve meaningfully alongside weight loss
Sermorelin's plasma half-life is roughly 10 to 12 minutes in humans, consistent with rapid N-terminal cleavage by dipeptidyl peptidase IV (DPP-IV)
Some cite results from the SURMOUNT trial on tirzepatide, noting ~26% lean mass loss